The protective effects of temporary immunity under imposed infection pressure

Epidemics

Volumn 4, Issue 1, 2012, Pages 43-47

  Swart, A N ^a   Tomasi, M ^d   Kretzschmar, M ^a,b   Havelaar, A H ^a,c   Diekmann, O ^d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Campylobacter; Immunity; SIR type model

Indexed keywords

ARTICLE; CAMPYLOBACTER; CAMPYLOBACTERIOSIS; DISEASE CARRIER; DISEASE PREDISPOSITION; HUMAN; IMMUNITY; MATHEMATICAL ANALYSIS; MODEL; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL;

CAMPYLOBACTER INFECTIONS; DISEASE OUTBREAKS; DISEASE RESERVOIRS; HUMANS; IMMUNITY; LIFE EXPECTANCY; LIKELIHOOD FUNCTIONS; MODELS, IMMUNOLOGICAL; MODELS, STATISTICAL;

EID: 84855886784     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2011.12.002     Document Type: Article

References (17)

1. Águas R., Gonçalves G., Gomes M.G.M. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect. Dis. 2006, 6(2006):2-7.
2. Ang C.W., Teunis P.F.M., Herbrink P., Keijser J., van Duynhoven Y.H.T.P., Visser C.E., van Pelt W. Seroepidemiological studies indicate frequent and repeated exposure to Campylobacter spp. during childhood. Epidemiol. Infect. 2011, 139:1361-1368. http://dx.doi.org/10.1017/S0950268810002359.
3. Black R.E., Levine M.M., Clements M.L., Hughes T.P., Blaser M.J. Experimental campylobacter jejuni infection in humans. J. Infect. Dis. 1988, 157(3):472-479.
4. Blaser M.J. Epidemiologic and clinical features of campylobacter jejuni infections. J. Infect. Dis. 1998, 176(Suppl 2):S103-S105.
5. Brunham R.C., Pourbohloul B., Mak S., White R., Rekart M.L. The unexpected impact of a chlamydia trachomatis infection control program on susceptibility to reinfection. J. Infect. Dis. 2005, 192:1836-1844.
6. Evers E.G., van der Fels-Klerx H.J., Nauta M.J., Schijven J.F., Havelaar A.H. Campylobacter source attribution by exposure assessment. Int. J. Risk Assess. Manage. 2008, 8(1-2):174-190.
7. Havelaar A.H., van Pelt W., Ang C.W., Wagenaar J.A., van Putten J.P.M., Gross U., Newell D.G. Immunity to campylobacter: its role in risk assessment and epidemiology. Crit. Rev. Microbiol. 2009, 35(1):1-22.
8. McBride, G.B., French, N.P., 2006. A new linear analytical sir model for age-dependent susceptibility and occupation-dependent immune status. In: Proceedings of the 6th WSEAS International Conference on Simulation, Modelling and Optimization, Stevens Point, Wisconsin, USA, 2006. World Scientific and Engineering Academy and Society (WSEAS), pp. 222-226, ISBN 111-9999-33-X. URL: http://portal.acm.org/citation.cfm?id=1369472.1369511.
9. Nagao Y., Koelle K. Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever. Proc. Natl. Acad. Sci. 105(6) 2008, 2238-2243.
10. Nauta M.J., Jacobs-Reitsma W.F., Havelaar A.H. A risk assessment model for campylobacter in broiler meat. Risk Anal. 2007, 27(4):845-861. ISSN: 1539-6924, http://dx.doi.org/10.1111/j.1539-6924.2006.00834.x.
11. Oberhelman R.A., Gilman R.H., Sheen P., Cordova J., Zimic M., Cabrera L., Meza R., Perez J. An intervention-control study of corralling of free-ranging chickens to control campylobacter infections among children in a peruvian periurban shantytown. Am. J. Trop. Med. Hyg. 2006, 74:1054-1059.
12. Teunis P.F.M., Havelaar A.H. The beta Poisson dose-response model is not a single-hit model. Risk Anal. 2002, 20(4):513-520.
13. Teunis P.F.M., Nagelkerke N.J.D., Haas C.N. Dose response models for infectious gastroenteritis. Risk Anal. 1999, 19:1251-1260.
14. Teunis, P.F.M., van Eijkeren, J.C.H., Ang, C.W., van Duynhoven, Y.T.H.P., Simonsen, J.B., Strid, M.A., van Pelt, W. Biomarker dynamics: estimating infection rates from serological data. Statist. Med., in press.
15. Tribble D.R., Baquar S., Scott D.A., Oplinger M.L., Trespalacios F., Rollins D., Walker R.I., Clemens J.D., Walz S., Gibbs P., Burg E.F., Moran A.P., Applebee L., Bourgeois A.L. Assessment of the duration of protection in campylobacter jejuni experimental infection in humans. Infect. Immun. 2010, 87(4):1750-1759.
16. Valentiner-Branth P., Steinsland H., Fischer T.K., Perch M., Scheutz F., Dias F., Aaby P., Kåre Mølbak, Sommerfelt H. Cohort study of guinean children: incidence pathogenicity conferred protection and attributable risk for enteropathogens during the first 2 years of life. J. Clin. Microbiol. 2003, 41(9):4238-4245.
17. WHO Global Health Observatory Database, 2010. http://apps.who.int/ghodata/?vid=720.